Republic Technologies Inc. (CSE:DOCT)
0.5600
-0.0300 (-5.08%)
Aug 15, 2025, 3:42 PM EDT
Republic Technologies Statistics
Total Valuation
CSE:DOCT has a market cap or net worth of CAD 20.23 million. The enterprise value is 20.06 million.
Market Cap | 20.23M |
Enterprise Value | 20.06M |
Important Dates
The next estimated earnings date is Wednesday, August 27, 2025.
Earnings Date | Aug 27, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 32.49M |
Shares Outstanding | n/a |
Shares Change (YoY) | +22.76% |
Shares Change (QoQ) | +91.03% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 16.90M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 159.20 |
P/TBV Ratio | 159.20 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -79.01 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.91
Current Ratio | 1.91 |
Quick Ratio | 1.28 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -134.64% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -295.08% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1,585.71% in the last 52 weeks. The beta is 7,652.59, so CSE:DOCT's price volatility has been higher than the market average.
Beta (5Y) | 7,652.59 |
52-Week Price Change | +1,585.71% |
50-Day Moving Average | 0.62 |
200-Day Moving Average | 0.25 |
Relative Strength Index (RSI) | 52.51 |
Average Volume (20 Days) | 53,740 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.28 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -374,916 |
Pretax Income | -333,722 |
Net Income | -253,931 |
EBITDA | n/a |
EBIT | -374,916 |
Earnings Per Share (EPS) | -0.03 |
Balance Sheet
The company has 172,996 in cash and n/a in debt, giving a net cash position of 172,996.
Cash & Cash Equivalents | 172,996 |
Total Debt | n/a |
Net Cash | 172,996 |
Net Cash Per Share | n/a |
Equity (Book Value) | 127,056 |
Book Value Per Share | 0.01 |
Working Capital | 127,056 |
Cash Flow
Operating Cash Flow | -99,328 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CSE:DOCT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -22.76% |
Shareholder Yield | n/a |
Earnings Yield | -1.26% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on December 30, 2022. It was a reverse split with a ratio of 0.1.
Last Split Date | Dec 30, 2022 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |